Czechia· CZ-0194798
BETMIGA
A mirabegron product containing mirabegron, registered in Czechia by Astellas Pharma Europe B.V., Leiden. The same ATC class is registered in 15 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Mirabegron is registered in 15 of 19 countries.
Countries holding a registration under ATC G04BD12 (mirabegron), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Mirabegron · ATC G04BD12
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirabegron costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mirabegron · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.84
The record
At a glance
SÚKL (Czech Republic)- Active substance
- MIRABEGRON
- Manufacturer
- Astellas Pharma Europe B.V., Leiden
- Country
- Czechia (CZ)
- ATC code
- G04BD12
- ATC class
- Mirabegron
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
100 interactions on record for mirabegron.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mirabegron · interactions on record
100 records
- 3 severe
- 26 moderate
- 71 minor
Most severe, free to view
- EliglustatA16AX10severe
- VenetoclaxL01XX52severe
- TamoxifenL02BA01severe
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mirabegron in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandBegiraxAristo Pharma GmbH
- SpainBAXIRTO 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGLaboratorios Alter S.A.
- PolandBegiraxAristo Pharma Sp. z o.o.
- FinlandBetmigaAstellas Pharma Europe B.V.
- United KingdomBetmiga 50mg modified-release tabletsDE Pharmaceuticals
- NetherlandsBetmiga 50 mg, tabletten met verlengde afgifteAstellas Pharma Europe B.V.
- United StatesMirabegronREMEDYREPACK INC.
- IrelandBetmiga 50 mg prolonged-release tabletsAstellas Pharma Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Mirabegron +pharma, Mirabegron G.L.
- Belgium · Mirabegron Eg, Mirabegron Teva
- Bulgaria · Иретиг, Мирабегрон G.L.
- Cyprus · Macitentan, Mirabegron
- Germany · Mirabegron Al, Mirabegron Aristo
- Denmark · Mirabegron Glenmark, Mirabegron Stada
- Estonia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Spain · Baxirto, Iretig
- Finland · Mirabegron Avansor, Mirabegron Glenmark
- France · Mirabegron Zentiva, Mirabegron Zentiva L.P.
- United Kingdom (Northern Ireland) · Mirabegron Altair, Mirabegron Aspire
- Greece · Iretig, Mirabegron Aristo Aristo
- Croatia · Iretig, Mezyran
- Hungary · Mirabegron Stada
- Ireland · Mirabegron Ascend, Mirabegron Clonmel
- Iceland · Betmiga, Iretig
- Italy · Iretig, Mirabegron Doc
- Liechtenstein · Betmiga
- Lithuania · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Luxembourg · Mirabegron Eg
- Latvia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Malta · Mirabegron, Mirabegron Clonmel
- Netherlands · Mirabegron Cf, Mirabegron Glenmark
- Norway · Betmiga, Mirabegron Glenmark
- Poland · Begirax, Iretig
- Portugal · Baxirto, Mirabegrom Alter
- Romania · Iretig, Mirabegron G.L. Pharma
- Sweden · Mirabegron Avansor, Mirabegron Glenmark
- Slovenia · Gozi 25 Mg, Gozi 50 Mg
- Slovakia · Mirabegron Glenmark, Mirabegron Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c06dd445-24ec-4dbf-a75b-3489823f8eb6 GET /v1/drugs/c06dd445-24ec-4dbf-a75b-3489823f8eb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL PRO",
"source": "sukl",
"strength": "50MG",
"pack_size": "50",
"substance": "MIRABEGRON",
"cz_kod_sukl": "0194798",
"product_type": "CH",
"substance_codes": "18120",
"registration_state": "R",
"registration_number": "EU/1/12/809/017"
}See everything about mirabegron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.